Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Iron Malabsorption: early-phase trial registry

1 of 2 indexed Iron Malabsorption trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Iron Malabsorption: 2 US clinical trials tracked, 1 recruiting.

Iron Malabsorption is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Illinois at Chicago, running 1 of these trials.

Enrollment posture brief

Registry condition iron-malabsorption

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Iron Malabsorption (this)50%
Open-enrollment share among volume-matched conditions near Iron Malabsorption

Iron Malabsorption lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Iron Malabsorption on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Iron Malabsorption is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Iron Malabsorption records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Plant-based high non-heme iron diet Other
1 trials
Low iron diet Other
1 trials
High heme iron diet Other
1 trials
Oral iron supplements Drug
1 trials
Ferumoxytol injection Drug
1 trials
Low Molecular Weight Iron Dextran Drug
1 trials
Darbepoetin Alfa Drug
1 trials

US sites by state

Facility locations filed on Iron Malabsorption trials. A trial with sites in several states counts in each.

Washington 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Iron Malabsorption page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Iron Malabsorption condition card totals 2 registered trials; most-linked intervention Plant-based high non-heme iron diet; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.